Learn More
With Trivastal, a double blind study including placebo control was carried out with 66 patients at the age between 55 and 67. These persons were patients of several practioners and were treated because of different phenomena of the neurovascular psychosyndrome. They received 1 dragee daily at the beginning of the treatment, then additional dragees up to the(More)
Up to now there has been scarcely any publication of precise tests on the duration (lasting effect) of psychotropical effects which have appeared in brain activity after conclusion of a longterm therapy with vasoactive or metabolical substances. In 32 patients with symptoms of arteriosclerosis (average 72 years) a six weeks trial treatment was carried out(More)
In previous pharmacological experiments with the choleretic agent Febuprol, healthy subjects showed a significant increase in bile flow and its constituents in the acute experiment. As a consequence of these results we have carried out a double-blind cross-over therapeutic trial with Febuprol in 50 patients with a cholecystopathic symptom complex. After a(More)
36 patients with psychosomatic symptoms were treated in a double blind study versus placebo with fluphenazine dekanoate (Dapotum D minor). They were tested before injection and on the 1st, 7th and 14th day. The patients were selected by the personality questionnaire of Maudsley (MMQ). All showed signs of neurotic reactions and vegetative instability. The(More)
We have carried out therapeutic trials in 20 orthostatic patients (ages ranging between 20 and 35 years) with unequivocal signs of a static-labile circulatory disturbance. The test programme was used three days per week over a three-week period (medication of Amphodyn-retard). The test programme consisted of measurements of the systolic and diastolic blood(More)